Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin
- 1 August 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 37 (2) , 247-252
- https://doi.org/10.1016/s0168-8278(02)00109-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Management of recurrent hepatitis C after liver transplantation: a concise reviewAmerican Journal of Gastroenterology, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Treatment of recurrent hepatitis c virus infection after liver transplantation with interferon and ribavirinTransplantation Proceedings, 1998
- Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantationHepatology, 1997
- Long-Term Outcome of Hepatitis C Infection after Liver TransplantationNew England Journal of Medicine, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- BIOCHEMICAL AND HISTOLOGIC EVALUATION OF RECURRENT HEPATITIS C FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1994
- Detection of hepatitis C virus RNA by reverse-transcriptase and polymerase chain reaction: clinical applications of quantitative analysisClinical and Diagnostic Virology, 1994
- Hepatocellular transferrin receptor expression in secondary siderosisLiver International, 1989